# Filing Detail

Form DEFC14A - Definitive proxy statement, contested solicitations:
SEC Accession No. 0001193125-25-087127
Filing Date
2025-04-21
Accepted
2025-04-21 15:21:01
Documents
3

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFC14A | d941014ddefc14a.htm | DEFC14A | 364314
2 | GRAPHIC | g941014g48g48.jpg | GRAPHIC | 260027
3 | GRAPHIC | g941014g49g49.jpg | GRAPHIC | 302015
| Complete submission text file | 0001193125-25-087127.txt |  | 1140353

Mailing Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608
Business Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608 5108485100
DYNAVAX TECHNOLOGIES CORP (Subject) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFC14A | Act: 34 | File No.: 001-34207 | Film No.: 25852726
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 200 GREENWICH AVENUE 3RD FLOOR GREENWICH CT 06830
Business Address 200 GREENWICH AVENUE 3RD FLOOR GREENWICH CT 06830 2034090812
Deep Track Capital, LP (Filed by) CIK: 0001856083 (see all company filings)

EIN.: 853360885 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFC14A